Kanamycin in the therapy of pulmonary tuberculosis in the United States.
作者信息
Kass I
出版信息
Ann N Y Acad Sci. 1966 Jun 14;132(2):892-900. doi: 10.1111/j.1749-6632.1966.tb43010.x.
Abstract
摘要
相似文献
1
Kanamycin in the therapy of pulmonary tuberculosis in the United States.
Ann N Y Acad Sci. 1966 Jun 14;132(2):892-900. doi: 10.1111/j.1749-6632.1966.tb43010.x.
2
The susceptibility of mycobacteria to rifamide and rifampicin.分枝杆菌对利福米特和利福平的敏感性。
Tubercle. 1967 Jun;48(2):144-8. doi: 10.1016/s0041-3879(67)80009-6.
3
The effect of radiation on microbiologic characteristics of M tuberculosis.
Chest. 1974 Sep;66(3):240-3. doi: 10.1378/chest.66.3.240.
4
[Determination of drug sensitivity of Mycobacterium tuberculosis by means of potassium tellurite].
Antibiotiki. 1969 Apr;14(4):323-5.
5
6
Trends in the prevalence of primary drug resistance in pulmonary tuberculosis in France from 1962 to 1970: a national survey.1962年至1970年法国肺结核原发性耐药率的趋势：一项全国性调查。
Tubercle. 1972 Jun;53(2):57-83. doi: 10.1016/0041-3879(72)90022-0.
7
8
Improvement of drg-sensitivity tests on tubercle bacilli.
Tubercle. 1970 Mar;51(1):68-75. doi: 10.1016/0041-3879(70)90129-7.
9
[Therapy of pulmonary tuberculosis in its current aspects].
Bibl Tuberc. 1965;20:59-70.
10
[Drug sensitivity of the so-called atypical mycobacteria].[所谓非典型分枝杆菌的药物敏感性]
Ann Ist Carlo Forlanini. 1968;28(1):25-41.
引用本文的文献
1
Antibacterial Drugs today: II.当今的抗菌药物：II。
Drugs. 1975;10(2):81-111. doi: 10.2165/00003495-197510020-00001.
Zotero 插件